A Randomized Trial of the Impact of Ferric Citrate on Erythropoietin and Intravenous Iron Use in Patients Receiving Dialysis.

Saved in:
Bibliographic Details
Title: A Randomized Trial of the Impact of Ferric Citrate on Erythropoietin and Intravenous Iron Use in Patients Receiving Dialysis.
Authors: Block GA; US Renal Care, Plano, Texas, USA., Mizani MR; South Texas Renal Care Group, San Antonio, Texas, USA., Broumand V; South Texas Renal Care Group, San Antonio, Texas, USA., Newby FD; Nephrology and Hypertension Specialists, PC, Dalton, Georgia, USA., Erinle A; High Desert Nephrology Associates, Gallup, New Mexico, USA., Arias C; South Texas Renal Care Group, San Antonio, Texas, USA., Block M; US Renal Care, Plano, Texas, USA., Brillhart S; US Renal Care, Plano, Texas, USA, stephanie.brillhart@usrenalcare.com., Leppink A; US Renal Care, Plano, Texas, USA., Danese M; Outcomes Insights Inc, Calabasas, California, USA., Dittrich M; US Renal Care, Plano, Texas, USA.
Source: American journal of nephrology [Am J Nephrol] 2024; Vol. 55 (5), pp. 520-528. Date of Electronic Publication: 2024 Jul 15.
Publication Type: Journal Article; Randomized Controlled Trial; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Karger Country of Publication: Switzerland NLM ID: 8109361 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1421-9670 (Electronic) Linking ISSN: 02508095 NLM ISO Abbreviation: Am J Nephrol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first